儿童宫内人类免疫缺陷病毒及抗逆转录病毒药物暴露的标准化定义
在HIV高流行国家,高达30%的孕妇感染HIV,胎儿暴露于HIV和抗逆转录病毒治疗;无HIV但感染风险高的孕妇也越来越多接受暴露前预防。建立儿童宫内HIV和抗逆转录病毒暴露的统一定义,有助于解读单个研究结果和跨队列比较。
要点
- 高达30%的孕妇感染HIV,胎儿同时暴露于HIV和抗逆转录病毒治疗。
- 无HIV但高风险孕妇接受抗逆转录病毒暴露前预防,胎儿仅暴露于药物。
- 统一宫内暴露定义有助于未来观察性研究和临床试验中暴露分类。
核心结论
- 提出的定义提供统一方法,以促进一致描述和估计HIV及抗逆转录病毒暴露对关键儿童健康结局的影响。
研究设计与样本
- 原文未报告研究方法与样本。
主要发现
- 在HIV高流行国家,高达30%的孕妇感染HIV,胎儿暴露于HIV和抗逆转录病毒治疗。
- 无HIV但感染风险高的孕妇越来越多接受抗逆转录病毒暴露前预防。
- 正投入建立和随访儿童队列以评估宫内HIV和抗逆转录病毒暴露的长期影响。
- 对相关暴露和结局的关键定义达成一致,对解读单个研究结果和跨队列比较均重要。
- 统一的宫内HIV和抗逆转录病毒药物(母亲治疗或暴露前预防)暴露定义将有助于未来观察性研究和临床试验中改进这些暴露的分类。
关键数值与推荐
- 原文未报告具体定义条款或推荐等级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In countries with high human immunodeficiency virus (HIV) prevalence, up to 30% of pregnant women are living with HIV, with fetal exposure to both HIV and antiretroviral therapy during pregnancy. In addition, pregnant women without HIV but at high risk of HIV acquisition are increasingly receiving HIV preexposure antiretroviral prophylaxis (PrEP). Investments are being made to establish and follow cohorts of children to evaluate the long-term effects of in utero HIV and antiretroviral exposure. Agreement on a key set of definitions for relevant exposures and outcomes is important both for interpreting individual study results and for comparisons across cohorts. Harmonized definitions of in utero HIV and antiretroviral drug (maternal treatment or PrEP) exposure will also facilitate improved classification of these exposures in future observational studies and clinical trials. The proposed definitions offer a uniform approach to facilitate the consistent description and estimation of effects of HIV and antiretroviral exposures on key child health outcomes.
引用
- Slogrove AL, Burmen B, Davies MA, et al. Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children. Clin Infect Dis. 2022. PMID: 35181789. doi:10.1093/cid/ciab974
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。